X4 Pharmaceuticals, Inc. (XFOR) Ownership

$0.74

south_east
-$0 (-0.28%)
Day's range
$0.68
Day's range
$0.77

X4 Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 02/14/2025 16.92 M $12.41 M   0.00% 8.42%
NEA MANAGEMENT COMPANY, LLC 02/14/2025 14.99 M $10.99 M   0.00% 7.46%
BLACKROCK FUNDING, INC. /DE 02/07/2025 11.06 M $8.11 M   -1.34% 5.51%
VANGUARD GROUP INC 02/11/2025 8.20 M $6.02 M   -2.84% 4.08%
02/14/2025 7.31 M $5.36 M   100.00% 3.64%
ORBIMED ADVISORS LLC 02/14/2025 7.13 M $5.23 M   0.00% 3.55%
KINGDON CAPITAL MANAGEMENT, L.L.C. 02/14/2025 4.94 M $3.62 M   6.43% 2.46%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 3.50 M $2.57 M   1.44% 1.74%
AXA S.A. 02/14/2025 3.07 M $2.25 M   -0.16% 1.53%
ENSIGN PEAK ADVISORS, INC 02/14/2025 2.55 M $1.87 M   0.00% 1.27%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 1.89 M $1.38 M   992.29% 0.94%
PALE FIRE CAPITAL SE 02/13/2025 1.40 M $1.03 M   -12.53% 0.70%
SCHONFELD STRATEGIC ADVISORS LLC 02/14/2025 1.39 M $1.02 M   -27.49% 0.69%
GSA CAPITAL PARTNERS LLP 02/07/2025 1.27 M $934,000   150.87% 0.63%
UBS OCONNOR LLC 02/14/2025 1.26 M $928,039   -18.39% 0.63%
UBS GROUP AG 02/14/2025 923,060 $677,526   253.49% 0.46%
GROUP ONE TRADING, L.P. 02/14/2025 797,411 $584,981   535.37% 0.40%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 650,000 $476,840   3.99% 0.32%
JANE STREET GROUP, LLC 02/14/2025 583,483 $428,043   134.85% 0.29%
GOLDMAN SACHS GROUP INC 02/11/2025 477,638 $350,395   63.25% 0.24%
JPMORGAN CHASE & CO 02/12/2025 459,653 $337,202   501.04% 0.23%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 438,208 $321,469   0.00% 0.22%
BANK OF NEW YORK MELLON CORP 02/04/2025 344,747 $252,906   0.00% 0.17%
DEUTSCHE BANK AG\ 02/14/2025 267,628 $195,369   559.56% 0.13%
BARCLAYS PLC 02/13/2025 266,157 $196,000   -4.15% 0.13%
MILLENNIUM MANAGEMENT LLC 02/14/2025 258,759 $189,826   -28.76% 0.13%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 233,500 $170,455   70.69% 0.12%
SIMPLEX TRADING, LLC 02/11/2025 191,904 $140,000   5,454.38% 0.10%
RHUMBLINE ADVISERS 01/30/2025 178,725 $131,174   0.14% 0.09%
KNOTT DAVID M JR 02/12/2025 154,071 $113,026   0.00% 0.08%
CITIGROUP INC 02/12/2025 137,207 $100,655   9.70% 0.07%
ALLIANCEBERNSTEIN L.P. 02/12/2025 109,570 $80,381   0.00% 0.05%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/14/2025 96,397 $70,717   4.48% 0.05%
COREBRIDGE FINANCIAL, INC. 02/11/2025 83,544 $61,288   -7.02% 0.04%
WELLS FARGO & COMPANY/MN 02/13/2025 78,518 $57,601   51.71% 0.04%
STIFEL FINANCIAL CORP 02/13/2025 75,607 $55,466   -38.25% 0.04%
VONTOBEL HOLDING LTD. 01/30/2025 75,000 $55,020   0.00% 0.04%
INVESCO LTD. 02/13/2025 62,073 $45,537   -49.85% 0.03%
ATRIA WEALTH SOLUTIONS, INC. 01/31/2025 60,000 $44,016   100.00% 0.03%
VOYA INVESTMENT MANAGEMENT LLC 02/14/2025 58,702 $43,064   0.00% 0.03%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 55,996 $41,000   0.00% 0.03%
NEW YORK STATE COMMON RETIREMENT FUND 01/31/2025 51,639 $38,000   0.00% 0.03%
PROSHARE ADVISORS LLC 02/14/2025 47,325 $34,719   -25.48% 0.02%
TD WATERHOUSE CANADA INC. 02/13/2025 45,000 $33,525   0.00% 0.02%
CANTOR FITZGERALD, L. P. 02/14/2025 40,251 $29,528   100.00% 0.02%
WOLVERINE TRADING, LLC 02/14/2025 39,663 $32,052   100.00% 0.02%
02/11/2025 33,784 $24,784   100.00% 0.02%
PNC FINANCIAL SERVICES GROUP, INC. 02/07/2025 30,158 $22,136   0.00% 0.02%
INTEGRATED WEALTH CONCEPTS LLC 02/14/2025 30,000 $22,008   100.00% 0.01%
BNP PARIBAS ARBITRAGE, SNC 02/14/2025 29,301 $21,495   -28.03% 0.01%

X4 Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 121 institutional investors and hedge funds held shares of X4 Pharmaceuticals, Inc.. The most heavily invested institutionals were:

Bain Capital Life Sciences Investors, LLC: 16.92 M

NEA Management Company, LLC: 14.99 M

BlackRock Funding, Inc. /DE: 11.06 M

VANGUARD GROUP INC: 8.2 M

ORBIMED ADVISORS LLC: 7.13 M

KINGDON CAPITAL MANAGEMENT, L.L.C.: 4.94 M

49.68% of X4 Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 100.78 M shares in the last 24 months. This purchase volume represents approximately $74.58 M in transactions.